I am comparing three suppliers on documentation rather than on price.
I have read the primary source rather than the summary, which has left me with more questions.
I understand the headline. I do not understand the footnotes, and the footnotes look important.
What would I need in addition before this supported a decision?
The short version: research-use designation is a labelling convention, not a legal exemption, and it does not travel across borders.
Some jurisdictions provide a limited personal-importation allowance for medicines, usually bounded by quantity, by a supply period and by a requirement that the substance is for the importer's own use. Others provide none.
It helps to be literal here: the authority that matters is the national medicines regulator plus the customs authority, and both usually publish their position in plain language on their own websites.
Nothing here is medical advice, and research-use compounds are not approved for human use in any jurisdiction.
If the stakes are material, ask a lawyer where you live rather than a forum anywhere.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsAnswering this needs the country, and even then the answer is a pointer to the relevant authority rather than a ruling.
Most agents discussed on this site are prescription-only medicines where they are licensed at all, which places personal importation under medicines regulation rather than under drug-control law in most jurisdictions.
Enforcement posture and legal position are not the same thing. Consignments arriving without incident establish nothing about the underlying rule.
Personal-importation allowances for medicines exist in some jurisdictions with quantity and supply-period limits, and are absent in others.
Prior successful deliveries tell you about enforcement, not about legality.
Start with the classification of the specific substance where you live, because the answer differs by substance and not only by country.
Onward supply — including at cost, including to friends — is treated separately and much more seriously in most regimes than importation for personal use.
Three broad categories cover most cases: controlled or scheduled substances, prescription-only medicines, and unclassified chemicals. The rules, penalties and enforcement posture differ sharply between them.
Research-use labelling is a seller's statement, not a legal category for you.
Worth being precise here: "For research use only" is a statement by the seller about intended use, and it binds nobody.
If the amount at stake is material, this is a question for a lawyer in your jurisdiction rather than for a forum in any jurisdiction.
Onward supply is a materially different legal act and should not be assumed to follow the same rule as personal importation.
Look up your own regulator and customs authority. They publish the answer directly.
The relevant detail is that this is the tag where the site is least able to help and most obliged to say so plainly.
A research-use-only label is a supplier's statement about intended use. It has no status in customs classification and does not create an exemption for the importer.
The caveat is the whole answer: nothing here is legal advice and the rule that applies to you is local.
Personal importation and onward supply are different acts under different rules.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.